GlassScriptPhysician profile
Uzma Khan
NPI 1538507785
$2,269.07
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.44 · 2020: $319 · 2021: $214 · 2022: $15.77 · 2023: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,555 · Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,554.80 |
| Food and Beverage | $102.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $1,669.19 | 2020-2023 | |
| Novo Nordisk INC | $204.88 | 2020-2021 | |
| Pfizer INC. | $56.73 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $54.02 | 2020-2021 | |
| Amgen INC. | $46.22 | 2020-2022 | |
| Abbvie INC. | $42.35 | 2021 | |
| Glaxosmithkline, LLC. | $41.87 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.12 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $30.15 | 2021 | |
| Sanofi Pasteur INC. | $26.23 | 2019 | |
| Esperion Therapeutics, INC. | $23.24 | 2020 | |
| Amarin Pharma, INC. | $19.37 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.70 | 2020 |
8 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uzma Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.